Literature DB >> 10443822

Course of proptosis in patients with Graves' disease after endoscopic orbital decompression.

S O Ulualp1, B M Massaro, R J Toohill.   

Abstract

AIM: To evaluate the results of follow-up and postoperative course of proptosis in patients with Graves' disease who underwent combined transconjunctival and transnasal endoscopic orbital decompression.
METHODS: Charts of patients with Graves' disease who underwent orbital decompression using combined transconjunctival and transnasal endoscopic technique were reviewed. The surgical technique involved preservation of the strut of bone between the lamina papyracea of the ethmoid and floor of the orbit of the maxilla. Data pertaining to patient demographics, previous treatments for orbital manifestations of Graves' disease, and preoperative and postoperative otolaryngologic and ophthalmologic examination findings were obtained. Postoperative course of reduction in proptosis was evaluated based on Hertel exophthalmometry measurements obtained in four intervals: 1) 0 to 1 month, 2) 1 month to 3 months, 3) 3 to 6 months, 4) 6 to 12 months.
RESULTS: Twenty-eight orbital decompressions were performed on 15 patients. All patients were unresponsive to corticosteroids and orbital irradiation. Ten orbits exhibited preoperative and postoperative visual acuity of 20/20. Vision improved in nine orbits and did not change in six orbits. Proptosis was reduced in 25 orbits. Postoperative course of reduction in proptosis varied within year 1, with the smallest proptosis measurements documented between 6 and 12 months.
CONCLUSIONS: Combined transconjunctival and transnasal endoscopic orbital decompression with preservation of the strut resulted in regression of proptosis, marked reduction in postoperative diplopia development, and improvement of visual acuity in patients with Graves' disease. Course of reduction in proptosis varied within postoperative 1 year, with the biggest reduction occurring between 6 and 12 months.

Entities:  

Mesh:

Year:  1999        PMID: 10443822     DOI: 10.1097/00005537-199908000-00006

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

Review 1.  Pharmacological treatments for thyroid eye disease.

Authors:  Sara P Modjtahedi; Bobeck S Modjtahedi; Ahmad M Mansury; Dinesh Selva; Raymond S Douglas; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Outcomes of endoscopic orbital decompression for graves' ophthalmopathy.

Authors:  Robbie S R Woods; Qistina Pilson; Natallia Kharytaniuk; Lorraine Cassidy; Rizwana Khan; Conrad V I Timon
Journal:  Ir J Med Sci       Date:  2019-06-16       Impact factor: 1.568

Review 3.  Surgical complications in orbital decompression for Graves' orbitopathy.

Authors:  S Sellari-Franceschini; I Dallan; A Bajraktari; G Fiacchini; M Nardi; R Rocchi; C Marcocci; M Marinò; A P Casani
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-08       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.